Nifty
Sensex
:
:
11987.65
40648.47
-11.45 (-0.10%)
-3.17 (-0.01%)

Pharmaceuticals & Drugs

Rating :
71/99  (View)

BSE: 532488 | NSE: DIVISLAB

1753.20
-10.40 (-0.59%)
21-Nov-2019 | 12:04PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1763.55
  •  1779.95
  •  1746.10
  •  1763.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  261029
  •  4576.36
  •  1797.80
  •  1420.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 46,810.07
  • 36.31
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 46,800.41
  • 0.91%
  • 6.61

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.01%
  • 2.33%
  • 8.08%
  • FII
  • DII
  • Others
  • 0.26%
  • 15.21%
  • 22.11%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.04
  • 9.61
  • 6.64

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.21
  • 9.73
  • 5.16

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.50
  • 9.49
  • 8.16

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.52
  • 29.68
  • 32.07

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.71
  • 5.82
  • 5.15

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.38
  • 19.73
  • 19.30

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Net Sales
1,445.57
0.00
0.00
1,162.88
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
955.01
0.00
0.00
775.74
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
490.56
0.00
0.00
387.14
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
33.94%
0.00%
33.29%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
47.03
0.00
0.00
30.32
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
3.79
0.00
0.00
0.32
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
45.93
0.00
0.00
43.83
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
487.87
0.00
0.00
373.31
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
131.09
0.00
0.00
100.87
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
356.78
0.00
0.00
272.44
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
24.68%
0.00%
23.43%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
13.44
0.00
0.00
10.26
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
2,532.14
2,144.84
1,863.87
1,316.54
941.62
Net Sales Growth
-
27.10%
-4.25%
7.63%
21.23%
23.02%
18.06%
15.07%
41.57%
39.82%
 
Cost Of Goods Sold
-
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
914.15
798.63
761.64
512.82
303.19
Gross Profit
-
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
1,617.99
1,346.21
1,102.23
803.72
638.44
GP Margin
-
63.10%
60.58%
62.26%
60.14%
61.05%
63.90%
62.77%
59.14%
61.05%
67.80%
Total Expenditure
-
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
1,516.76
1,328.87
1,172.59
815.64
536.35
Power & Fuel Cost
-
248.66
228.73
198.80
180.34
170.82
147.40
131.02
86.13
62.65
45.13
% Of Sales
-
5.03%
5.88%
4.89%
4.78%
5.48%
5.82%
6.11%
4.62%
4.76%
4.79%
Employee Cost
-
542.27
456.06
499.90
361.19
290.42
232.46
197.72
150.85
117.23
73.35
% Of Sales
-
10.96%
11.72%
12.30%
9.56%
9.32%
9.18%
9.22%
8.09%
8.90%
7.79%
Manufacturing Exp.
-
212.96
182.67
169.15
169.42
147.24
121.10
104.85
86.61
65.13
44.86
% Of Sales
-
4.31%
4.69%
4.16%
4.49%
4.73%
4.78%
4.89%
4.65%
4.95%
4.76%
General & Admin Exp.
-
105.42
139.33
88.22
73.91
63.85
51.74
44.15
32.47
27.57
46.78
% Of Sales
-
2.13%
3.58%
2.17%
1.96%
2.05%
2.04%
2.06%
1.74%
2.09%
4.97%
Selling & Distn. Exp.
-
73.08
64.02
67.48
56.04
51.93
44.22
51.29
53.63
29.80
19.93
% Of Sales
-
1.48%
1.65%
1.66%
1.48%
1.67%
1.75%
2.39%
2.88%
2.26%
2.12%
Miscellaneous Exp.
-
65.63
23.87
59.65
11.80
11.18
5.69
1.21
1.27
0.44
19.93
% Of Sales
-
1.33%
0.61%
1.47%
0.31%
0.36%
0.22%
0.06%
0.07%
0.03%
0.33%
EBITDA
-
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
1,015.38
815.97
691.28
500.90
405.27
EBITDA Margin
-
37.87%
32.45%
35.61%
37.56%
37.44%
40.10%
38.04%
37.09%
38.05%
43.04%
Other Income
-
155.63
113.44
74.89
97.44
44.70
70.60
44.81
56.05
27.12
34.33
Interest
-
4.68
2.37
3.36
4.74
2.88
2.96
2.59
4.61
2.26
2.78
Depreciation
-
168.90
142.49
123.33
118.18
136.00
92.12
76.95
62.08
53.40
51.48
PBT
-
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
680.63
472.37
385.33
Tax
-
502.33
354.32
334.92
267.06
220.56
217.58
179.23
147.36
43.10
44.99
Tax Rate
-
27.08%
28.78%
24.00%
19.17%
20.57%
21.96%
22.94%
21.65%
9.12%
11.68%
PAT
-
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
533.26
429.27
340.34
PAT before Minority Interest
-
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
533.26
429.27
340.34
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
27.35%
22.54%
26.09%
29.81%
27.34%
30.54%
28.07%
28.61%
32.61%
36.14%
PAT Growth
-
54.24%
-17.30%
-5.81%
32.21%
10.11%
28.46%
12.89%
24.22%
26.13%
 
Unadjusted EPS
-
50.96
33.04
39.95
42.41
32.08
58.26
45.35
40.19
32.42
26.11

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
2,963.35
2,500.60
2,131.52
1,797.48
1,517.80
Share Capital
53.09
53.09
53.09
53.09
26.55
26.55
26.55
26.55
26.52
26.43
Total Reserves
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
2,936.80
2,474.05
2,104.98
1,769.98
1,487.22
Non-Current Liabilities
991.38
1,768.91
1,411.75
85.17
841.57
650.05
469.75
71.35
67.39
80.26
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.18
29.85
Unsecured Loans
0.00
0.00
0.00
0.47
1.05
1.55
2.10
2.56
2.74
3.00
Long Term Provisions
772.54
1,577.26
1,288.92
11.57
714.30
533.49
388.43
1.65
2.82
0.00
Current Liabilities
846.75
653.42
659.45
519.50
775.53
627.41
554.45
553.78
409.90
260.79
Trade Payables
492.26
411.21
445.80
232.69
226.87
151.70
160.44
159.54
123.00
158.26
Other Current Liabilities
243.59
175.46
176.63
240.58
203.45
147.80
130.08
135.83
105.35
6.08
Short Term Borrowings
105.60
63.11
35.74
41.42
25.07
16.32
30.51
50.20
13.62
0.00
Short Term Provisions
5.30
3.64
1.28
4.81
320.14
311.58
233.42
208.21
167.92
96.44
Total Liabilities
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
4,240.81
3,524.80
2,756.65
2,274.77
1,858.85
Net Block
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
1,221.84
908.72
738.42
589.93
589.84
Gross Block
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
1,740.34
1,338.35
1,092.05
885.70
832.93
Accumulated Depreciation
546.16
377.26
234.76
757.32
644.13
518.50
429.63
353.64
295.77
243.10
Non Current Assets
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
1,984.45
1,660.69
1,005.71
734.07
613.59
Capital Work in Progress
491.91
119.76
443.57
263.91
218.18
144.48
303.41
181.58
103.72
23.75
Non Current Investment
547.26
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
1,012.93
1,688.23
1,406.48
162.44
812.63
618.03
448.49
83.68
38.20
0.00
Other Non Current Assets
5.36
7.82
8.83
5.80
0.35
0.09
0.07
1.63
1.60
0.00
Current Assets
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
2,256.35
1,864.11
1,750.95
1,540.71
1,245.27
Current Investments
1,398.34
1,889.28
1,630.72
802.85
733.00
501.88
407.81
477.04
525.64
441.27
Inventories
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
932.42
835.69
678.96
571.71
498.50
Sundry Debtors
1,163.37
1,014.36
900.92
880.92
741.64
723.70
512.00
495.08
365.23
223.20
Cash & Bank
115.26
112.46
78.70
73.43
65.22
40.51
40.89
30.94
17.67
16.46
Other Current Assets
200.74
124.98
20.67
19.13
69.89
57.85
67.71
68.93
60.46
65.82
Short Term Loans & Adv.
58.54
43.37
59.59
42.88
54.98
48.16
57.97
63.25
57.36
64.14
Net Current Assets
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
1,628.95
1,309.66
1,197.16
1,130.81
984.48
Total Assets
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46
4,240.80
3,524.80
2,756.66
2,274.78
1,858.86

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
954.30
775.86
1,150.37
1,037.86
826.33
556.75
479.97
338.36
326.55
369.35
PBT
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
680.63
472.37
385.33
Adjustment
83.51
32.19
93.87
60.94
91.24
77.55
59.25
26.87
26.87
22.75
Changes in Working Capital
-499.84
-219.11
-37.14
-155.03
-125.55
-298.39
-186.05
-242.47
-139.28
15.78
Cash after chg. in Working capital
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
770.07
654.44
465.03
359.97
423.86
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-484.44
-268.55
-301.70
-260.89
-211.43
-213.32
-174.47
-126.68
-33.42
-54.51
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-685.40
-478.30
-1,139.60
-406.41
-520.84
-305.15
-254.54
-204.41
-221.31
-317.18
Net Fixed Assets
-632.52
-255.54
222.19
-288.75
-286.31
-242.98
-368.08
-284.15
-132.66
-54.41
Net Investments
-56.30
-257.57
-826.05
-77.22
-231.12
-94.07
69.23
48.60
-86.61
-269.47
Others
3.42
34.81
-535.74
-40.44
-3.41
31.90
44.31
31.14
-2.04
6.70
Cash from Financing Activity
-245.94
-314.16
2.38
-631.12
-302.95
-248.50
-230.76
-131.11
-104.16
-47.60
Net Cash Inflow / Outflow
22.96
-16.60
13.15
0.33
2.54
3.10
-5.33
2.84
1.09
4.57
Opening Cash & Equivalents
-20.86
-4.26
-17.41
17.62
15.09
11.99
17.32
14.48
13.39
8.82
Closing Cash & Equivalent
2.10
-20.86
-4.26
17.95
17.62
15.09
11.99
17.32
14.48
13.39

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
262.09
223.20
201.82
161.73
131.67
111.63
94.20
80.29
67.74
57.27
ROA
15.78%
11.12%
17.21%
22.49%
18.21%
19.92%
19.17%
21.20%
20.77%
19.98%
ROE
21.00%
15.55%
21.98%
28.91%
26.37%
28.31%
25.99%
27.15%
25.94%
24.89%
ROCE
28.50%
21.68%
28.75%
35.57%
33.06%
36.04%
33.21%
34.20%
28.16%
27.29%
Fixed Asset Turnover
1.98
1.88
2.06
1.83
1.70
1.66
1.78
1.90
1.55
1.17
Receivable days
80.35
89.33
79.19
77.83
85.12
88.42
85.08
83.45
80.71
94.24
Inventory Days
115.23
124.56
112.34
113.70
121.69
126.52
127.96
121.31
146.79
177.19
Payable days
52.21
60.15
47.14
35.06
33.55
36.16
42.47
42.66
63.49
109.78
Cash Conversion Cycle
143.37
153.75
144.39
156.47
173.26
178.78
170.58
162.09
164.00
161.65
Total Debt/Equity
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.02
Interest Cover
397.38
520.55
416.28
294.75
373.59
336.24
302.96
148.53
210.46
139.64

News Update


  • USFDA inspects Divi’s Laboratories’ Unit-I Telangana
    15th Nov 2019, 12:01 PM

    The inspection has been concluded with no 483 observations

    Read More
  • Divi’s Laboratories’ consolidated net profit dips 12% in Q2
    6th Nov 2019, 11:12 AM

    Total consolidated income of the company increased by 6.28% at Rs 1,492.60 crore for Q2FY20

    Read More
  • Divis Lab - Quarterly Results
    5th Nov 2019, 18:02 PM

    Read More
  • HPRA, JAZMP inspect Divi’s Laboratories’ Unit-2 Vishakhapatnam
    31st Aug 2019, 09:17 AM

    The inspection has concluded successfully with no critical observations

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.